FlexSure vs V30 (2026)

New price range

Cynosure FlexSure

$40k–$70kSource not documented

Viora V30 / V-FORM

$40k–$70kSource not documented

Used asking range

Cynosure FlexSure

Not published

Viora V30 / V-FORM

Not published

Payback calculator

Cynosure FlexSure

View ROI calculator

Viora V30 / V-FORM

View ROI calculator

Consumable cost / lock-in

Cynosure FlexSure

—

Viora V30 / V-FORM

Essentially none beyond conductive gel — a genuine advantage over tip-based devices. Handpiece replacement (several thousand each) is the real long-run cost as applicators age out.

Service cost

Cynosure FlexSure

Not published

Viora V30 / V-FORM

Not published

FDA status & indication

Cynosure FlexSure

FDA ClearedK200241

Read FDA indication wording

“The TempSure™ System has the following indications for use: The 10mm, 15mm, and 20mm Smart Handpieces are indicated for non-ablative treatment of mild to moderate facial wrinkles and rhytids. The 18mm, 25mm, 30mm, 60mm Smart Handpieces and FlexSure™ applicators provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The massage device is intended to provide a temporary reduction in the appearance of cellulite. The following surgical modes are applicable to the generator: Coagulation/Hemostasis: General surgical procedures including urologic, thoracic, plastic, reconstructive, and gynecological procedures where electrosurgical coagulation of tissue is performed. Cutting: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin incisions, biopsy, cysts, abscesses, tumors, cosmetic repairs, development of skin flaps, skin tags and blepharoplasty. Blended Cutting and Coagulation: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin tags, papilloma keloids, keratosis, verrucae, basal cell carcinoma, nevi, fistulas, epithelioma, cosmetic repairs, cysts, abscesses, and development of skin flaps. Fulguration: basal cell carcinoma, papilloma, cyst destruction, tumors, verrucae, hemostasis. Bipolar: pinpoint precise coagulation, pinpoint hemostasis in any field (wet or dry), snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment and turbinate shrinkage.”

Viora V30 / V-FORM

FDA ClearedK133837

Read FDA indication wording

“The Viora V-total 7"' isintended for dermatological procedures. The ST handpiece is indicated for the treatment of relief of minor muscle aches and pain, relief of muscle spasm and temporary improvement of local blood circulation. The IPL handpiece with wavelengths 415-l200nm (with 5 different filters) is indicated for the treatment of:. * Moderate inflammatory acne vulgaris. * Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasrna, and ephelides (freckles). * Cutaneous lesions including warts, scars and striae. "Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacca, erythema of rosacca, angiomnas and spider angiomnas, poikiloderma of Civatte and venous malformations. * Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction inthe number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Nd:YAG Laser handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm. The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for: - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias). reticular veins (0. 1-4.0mmn dia.) of the leg, rosace, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. * Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. * Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of One, chloasma, verrucae, skin tags and keratosis. - Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. ' The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. "The handpiece with a spot size of 9.5 mm is also intended for treatment of: Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral pant of the scar.”

Chain adoption

Cynosure FlexSure

0 recorded pairings

Viora V30 / V-FORM

0 recorded pairings

Chains using it

Cynosure FlexSure

—

Viora V30 / V-FORM

—

Approved reviews

Cynosure FlexSure

0

Viora V30 / V-FORM

0

Manufacturer

Cynosure FlexSure

Cynosure

Viora V30 / V-FORM

Viora

Built by (OEM)

Cynosure FlexSure

Cynosure LLC

Viora V30 / V-FORM

Viora Ltd.

Category

Cynosure FlexSure

Body Contouring

Viora V30 / V-FORM

Body Contouring

Technology

Cynosure FlexSure

Wrap-around hands-free RF applicators

Viora V30 / V-FORM

Multi-CORE RF + vacuum

Launch year

Cynosure FlexSure

2021

Viora V30 / V-FORM

2018

Status

Cynosure FlexSure

Current

Viora V30 / V-FORM

Current

Manufacturer source record

Cynosure FlexSure

No linked source on file.

Viora V30 / V-FORM

No linked source on file.